摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Cyclopentyl-3-(4-methoxyphenyl)-1-(2-phenylethyl)piperazine-2,5-dione

中文名称
——
中文别名
——
英文名称
4-Cyclopentyl-3-(4-methoxyphenyl)-1-(2-phenylethyl)piperazine-2,5-dione
英文别名
——
4-Cyclopentyl-3-(4-methoxyphenyl)-1-(2-phenylethyl)piperazine-2,5-dione化学式
CAS
——
化学式
C24H28N2O3
mdl
——
分子量
392.5
InChiKey
YGLQFADYNCLGSG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    29
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    49.8
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • COMPOSITIONS AND METHODS FOR TREATING, PREVENTING AND DIAGNOSING CANCER AND OTHER PROLIFERATIVE DISORDERS
    申请人:Angiogenex, Inc.
    公开号:EP3079680A2
    公开(公告)日:2016-10-19
  • [EN] COMPOSITIONS AND METHODS FOR TREATING, PREVENTING AND DIAGNOSING CANCER AND OTHER PROLIFERATIVE DISORDERS<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT, DE PRÉVENTION ET DE DIAGNOSTIC DU CANCER ET D'AUTRES MALADIES PROLIFÉRATIVES
    申请人:ANGIOGENEX INC
    公开号:WO2015089495A2
    公开(公告)日:2015-06-18
    The present invention provides methods for impairing function or reducing or ablating levels of Id (inhibitors of differentiation) proteins to suppress metastasis of cancer cells in mammalian subjects presenting with cancer or elevated risk of metastatic disease. Exemplary anti-Id compounds include N-(3-(benzo[d] [1,3]dioxol-5-yl)-3-(2-methoxyphenyl)propyl)-N- benzylpropionamide and isolated enantiomers of N-(3-(benzo[d] [ 1,3]dioxol-5-yl)-3-(2- methoxyphenyl)propyl)-N-benzylpropionamide. Anti-Id compositions and methods of the invention can be combined with standard anticancer treatment modalities, such as surgery, radiation and chemotherapy. Also provided are compositions and methods to treat other hyperproliferative disorders, including pathogenic angiogenic conditions, including tumor-associated neoangiogenesis and ocular vascular pathologies including age-related macular degeneration.
查看更多